Phase I/II Study of the Poly (ADP-Ribose) Polymerase-1 (PARP-1) Inhibitor BSI-201 in Patients with Newly Diagnosed Malignant Glioma

Grant

Date/time Interval

  • June 4, 2012 - December 31, 2018

    • Awarded By

    Total Award Amount

  • 6000.00

    • Direct Costs

  • 4096.00

    • Sponsor Award Id

    • Contributor

  • Louis Nabors M.D.   Principal Investigator